The landscape of dementia analysis has developed considerably with the advent of sophisticated biomarkers, together with amyloid PET scans, tau imaging, and blood-based exams that could detect Alzheimer's pathology years ahead of symptoms emerge. Even though these technological advances symbolize outstanding development in comprehending neurodegene